Long‐term remission of Hailey–Hailey disease by Er:YAG ablative laser therapy

Marie‐Eline P. H. Debeuf,Kèvin Knoops,Carmen López‐Iglesias,Eline Lookermans,Patty J. Nelemans,Myrurgia Abdul Hamid,Michel van Geel,Antoni H. Gostynski,Peter M. Steijlen,Marieke C. Bolling,Valerie L. R. M. Verstraeten
DOI: https://doi.org/10.1111/jdv.20351
2024-10-03
Journal of the European Academy of Dermatology and Venereology
Abstract:Upper left panel: Hailey–Hailey lesion at baseline, directly after, 6 weeks and 3 years after a single Er:YAG laser ablation. Long‐term remission was noted in 75/77 Hailey–Hailey plaques after a median follow‐up of 38 months. Upper right panel: Median quality of life scores at baseline, 6 weeks and 3 years after laser ablation with a significant improvement at 6 weeks and 3 years after laser ablation. Bottom left panel: Electron microscopy of keratinocytes in the stratum spinosum at baseline and 6 weeks after laser ablation. Laser‐treated skin showed an increased number of desmosomes, decreased intercellular distance and decreased perinuclear retraction of keratin filaments. Bottom right panel: Cross‐section of the skin on the right side showing the depth of laser ablation. Laser ablation up to mid‐dermis induced long‐term remission of Hailey–Hailey disease. Background Hailey–Hailey disease (HHD) is a rare genetic therapy‐resistant blistering disease with great disease burden. Treatment is currently focused on symptomatic relief. Er:YAG ablative laser therapy is a therapeutic modality with promising results, though evidence is currently scarce. Objective To analyse the effect of Er:YAG ablative laser therapy on clinical remission of erosive plaques in HHD and on patient's quality of life (QoL). Methods In this observational study eight patients were included and 77 erosive plaques were treated once only by Er:YAG laser and assessed for clinical remission. QoL was evaluated by obtaining Skindex‐29 and DLQI questionnaires before laser therapy, 6 weeks and 3 years after laser therapy. Skin biopsies were taken to evaluate the depth of laser ablation. The intercellular distance between keratinocytes, the number of desmosomes and intermediate filament distribution were studied by electron microscopy before and after laser therapy and in clinically uninvolved skin and were compared to subjects without HHD. Results One single Er:YAG laser ablation to mid‐dermis resulted in complete remission of 97.4% of HHD plaques (75/77) after median 38 months (range 7–63 months) and significantly improved QoL. Laser therapy restored the number of desmosomes, decreased intercellular distance and diminished perinuclear retraction of keratin filaments to a level comparable to the patient's clinically uninvolved skin. After laser ablation, the skin showed significantly fewer ultrastructural aberrations compared to the patient's clinically uninvolved skin and rather resembled the skin of healthy control individuals. Conclusion One single Er:YAG laser treatment resulted in long‐term remission of HHD and significantly improved QoL. Our findings support a greater role for ablative laser surgery in the management of this recalcitrant disorder.
dermatology
What problem does this paper attempt to address?